| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/01/2004 | WO2002053094A8 Method for detoxifying a carbohydrate containing solution |
| 04/01/2004 | WO2002043654A8 Pharmaceutical composition and method for treatment of brain injury, spinal cord injury, stroke, neurodegenerative disease and other conditions |
| 04/01/2004 | US20040064039 Myocardial perfusion imaging method |
| 04/01/2004 | US20040063974 Antidepressants; anxiolytic agents; antiinflammatory agents; analgesics; antiemetics |
| 04/01/2004 | US20040063972 Therapy for bone disorders |
| 04/01/2004 | US20040063967 Antiinflammatory agents; sepsis shock; phospholipase inhibitors |
| 04/01/2004 | US20040063961 Enzyme inhibitors; antilipemic agents |
| 04/01/2004 | US20040063959 Esters and amides as PLA2 inhibitors |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063950 Carbamates derivatived from arylakylamines |
| 04/01/2004 | US20040063949 Controlling gene expression of tranforming growth factor |
| 04/01/2004 | US20040063944 Farnesyl transferase inhibiting 4-substituted quinoline and quinazoline derivatives |
| 04/01/2004 | US20040063943 Phosphodiesterase inhibitor; cardiovascular disorders; sexual disorders |
| 04/01/2004 | US20040063942 Spiro-indolines as Y5 receptor antagonists |
| 04/01/2004 | US20040063941 Novel spla2 inhibitors |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063929 Beta-lactam compounds process for reproducing the same and serum cholesterol-lowering agents containing the same |
| 04/01/2004 | US20040063926 L-nucleic acid derivative and processes for the synthesis thereof |
| 04/01/2004 | US20040063921 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 04/01/2004 | US20040063794 Vehicle for topical delivery of anti-inflammatory compounds |
| 04/01/2004 | US20040063792 Novel amorphous form of sertraline hydrochloride |
| 04/01/2004 | US20040063788 Use of abietic acid or derivative thereof for modulation permeability of plasma membrane |
| 04/01/2004 | US20040063787 Vaginal health products |
| 04/01/2004 | US20040063785 Symmetrically disubstituted aromatic compounds and pharmaceutical compositions for inhibiting poly (ADP-ribose) glycohydrolase, and methods for their use |
| 04/01/2004 | US20040063784 Treatment of abnormal increases in gastrointestinal motility with (R)-verapamil |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063781 Compounds active at the glucocorticoid receptor II |
| 04/01/2004 | US20040063780 Pharmaceutical preparations for treatment of type II diabetes and methods for treatment of type II diabetes |
| 04/01/2004 | US20040063779 For treatment and/or prevention of a diseases such as autoimmune or inflammatory diseases such as asthma or allergic diseases wherein the activity of a CCR3 receptor is involved |
| 04/01/2004 | US20040063776 2-oxo-1-pyrrolidineacetamide derivatives are useful for treating cancer pain and other neuropathic pain |
| 04/01/2004 | US20040063773 Adminstering a pyrrole substituted 2-indolinone compound to a human for the treatment of protein kinase related cellular disorders such as cancer, autoimmune disorders, diabetes, rheumatoid arthritis, angiogenesis and osteoarthritis |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063770 Method for treating Alzheimer's disease |
| 04/01/2004 | US20040063769 Combinations of drugs (e.g., a benzimidazole and pentamidine) for the treatment of neoplastic disorders |
| 04/01/2004 | US20040063768 Cyclopentylindole derivatives are useful for the treatment of depression, attention deficit hyperactivity disorder, obsessive-compulsive disorder, post-trauma stress, substance abuse and sexual disorders |
| 04/01/2004 | US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base |
| 04/01/2004 | US20040063766 Pharmaceutical composition containing aminocetonitrile compounds and the use thereof for the preparation of a pharmaceutical composition for the treatment of endoparasitic pests in animals |
| 04/01/2004 | US20040063765 Modulation of pathogenicity |
| 04/01/2004 | US20040063762 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063760 Sodium channel modulatiors |
| 04/01/2004 | US20040063759 Administering to a mammal, for treatment or prevention of conditions that can be treated or prevented by antagonizing the CCR1 receptor in a mammal, a piperidinone compound |
| 04/01/2004 | US20040063757 Urotensin-ll receptor antagonists |
| 04/01/2004 | US20040063755 Aromatic compounds containing hydroxyalkylaminoalkylphenylaminophenyl group; useful for treating pre-term labor, neurological disorders and cardiac disorders |
| 04/01/2004 | US20040063753 N-acetoamino-4-one-Pyridine derivatives are used as Lp-PLA2 (lipoprotein Associated Phospholipase A2) enzyme inhibitor |
| 04/01/2004 | US20040063752 Monotherapy for the treatment of amyotrophic lateral sclerosis with cyclooxygenase-2 (COX-2) inhibitor(s) |
| 04/01/2004 | US20040063751 Such as N-(2-cyclohexyloxynitrophenyl)methane sulfonamide |
| 04/01/2004 | US20040063750 Such as N-propanesulfonyl-((3R,5S)-7-chloro-5-(2,3-dimethoxyphenyl)-1-(3-hydroxy-2,2-dimethylpropyl)-2-oxo-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl) acetamide which has squalene synthase inhibitory activity |
| 04/01/2004 | US20040063748 Such as 2-(4-amino-2,3,5-trimethylphenoxy)-N-methyl-N-(4-piperidinyl)acetamide which has neuroprotective effects by inducing calcium binding proteins |
| 04/01/2004 | US20040063747 Local anesthetic methods and kits |
| 04/01/2004 | US20040063746 For treatment of HIV |
| 04/01/2004 | US20040063745 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 04/01/2004 | US20040063744 Such as 1-(4-(1-bromo-1-phenyl-methylene)-piperidin-1-yl)-2-(4,7-dimethoxy-6 -azaindol-3-yl)-ethane-1,2-dione for treatment of HIV and acquired immune deficiency syndrome |
| 04/01/2004 | US20040063743 Preparation of 1H-imidazo [4,5-C] quinolin-4-amines via novel 1H-imidazo [4,5-c] quinolin-4-cyano and 1H-imidazo [4,5-c] quinolin-4-carboxamide intermediates |
| 04/01/2004 | US20040063742 Such as 5-(4-Chlorophenyl)-8-methyl-6,7,8,9-tetrahydro-1-H-pyrrolo(3.2-h)isoquinoline-2,3-dione-3-oxime-(phenyl))urea; kits; drug screening |
| 04/01/2004 | US20040063741 Dopamine receptor agonist for treatment of movement disorders/Parkinson's disease |
| 04/01/2004 | US20040063736 Combination of active ingredients containing alfuzosine and apomorphine |
| 04/01/2004 | US20040063735 Calcitonin gene related peptide receptor antagonists |
| 04/01/2004 | US20040063734 4,4-Disubstituted-3,4-dihydro-2 (1H)-quinazoliniones useful as HIV reverse transcriptase inhibitors |
| 04/01/2004 | US20040063733 Quinazoline derivatives |
| 04/01/2004 | US20040063732 Such as trans-N2-(4-aminocyclohexyl)-N6-(2-aminoethyl)-1H-purine-2,6-diamine trihydrochloride for treatment/prevention of fungal diseases |
| 04/01/2004 | US20040063731 Pharmaceutical formulation comprising pyrazolo[4,3-d]pyrimidines and endothelin receptor antagonists or thienopyrimidines and endothelin receptor antagonists |
| 04/01/2004 | US20040063730 Such as 5-(7-(3-chloro-4-methoxybenzylamino-1-methyl-3-propyl-1 H-pyrazolo(4,3-d)pyrimidin-5-yl)pentanoic acid; phosphodiesterase inhibitors; for treatment of cardiovascular disorders, asthma, and allergies; kits |
| 04/01/2004 | US20040063727 Rheumatoid arthritis, lupus, type I diabetes, multiple sclerosis, cancer, restenosis; synthesis |
| 04/01/2004 | US20040063726 Methods and compounds for treating neurologic or neuropsychiatric disorders and identifying compounds to treat the same |
| 04/01/2004 | US20040063725 Binding neuropeptide Y receptors; hypertension, angina, atherosclerosis, depression, anxiety, inflammation, allergies |
| 04/01/2004 | US20040063723 One pot synthesis; formylation, oximination, cyanation, saponification and amidation of indole ester |
| 04/01/2004 | US20040063722 Antifungal ketoconazole composition for topical use |
| 04/01/2004 | US20040063721 Using endogenously produced serotonin reuptake inhibitor ligand |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063719 Combination therapy using antihypertensive agents and endothelin antagonists |
| 04/01/2004 | US20040063718 Targeted therapeutics and uses thereof |
| 04/01/2004 | US20040063717 Employing fatty acid oxidation inhibitor; lowering HbA1c, glucose, total cholesterol and/or triglyceride plasma levels; increasing high density lipoprotein concentration; minimizing side effects; ranolazine |
| 04/01/2004 | US20040063714 Triazolo-pyridazine derivatives as ligands for GABA receptors |
| 04/01/2004 | US20040063713 Such as 2-((4-(2-fluorophenyl)-1-piperazinyl)methyl)-1H-thieno(3,4-d)imidazole |
| 04/01/2004 | US20040063712 Disruption of signal transduction by inhibition of kinases in target cells |
| 04/01/2004 | US20040063711 Method for treating erectile dysfunction |
| 04/01/2004 | US20040063710 Ophthalmological preparations |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063708 Pyrrolotriazine kinase inhibitors |
| 04/01/2004 | US20040063707 Azaindole kinase inhibitors |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063704 Central nervous system disorders including depression and/or anxiety; 5-HT1 type receptor and/or serotonin reuptake inhibition activity |
| 04/01/2004 | US20040063701 Potent and specific serotonin 2 receptor inhibition with low adverse side effects; such as 1-formyl-N-(2-(4-(5H-dibenzo-(a,d)cyclohepten-5-ylidene)-1 -piperidinyl))ethylisonipecot-amide |
| 04/01/2004 | US20040063700 Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 04/01/2004 | US20040063697 Compositions of cyclooxygenase-2 selective inhibitors and thrombolytic agents for the treatment or prevention of a vaso-occlusive event |
| 04/01/2004 | US20040063696 Antiinflammatories targeting cartilage tissue; limiting side effects; arthritis, arthrosis |
| 04/01/2004 | US20040063695 Cystic fibrosis transmembrane conductance regulator protein inhibitors and uses thereof |
| 04/01/2004 | US20040063693 5-HT2A receptor related disorders; such as 1-(2-(2-fluoro-4-nitrophenoxy)ethyl)-3-(1piperazinyl)-2(1H)-pyrazinone |
| 04/01/2004 | US20040063692 Bazedoxifene treatment regimens |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063690 Cardiovascular disorders; guanylate cyclase activation; diseases associated with disturbed cyclic guanosine monophosphate balance |
| 04/01/2004 | US20040063689 Compositions containing alpha-2-adrenergic agonist components |
| 04/01/2004 | US20040063688 CCR1 receptor antagonists; such as 5-chloro-2-(2-(-3-(4-fluoro-phenoxy)-8-aza-bicyclo(3.2.1)oct-8-yl)-2-oxo -ethoxy)-benzamide |
| 04/01/2004 | US20040063687 Cardiac arrhythmias; potassium channel function inhibitors; such as 7-(3,4-Dichlorophenyl)-6-(5-fluoro-1-methyl-1H-benzimidazol-2-yl)-4,7 -dihydro-5-(methoxymethyl)pyrazolo-(1,5-a)pyrimidine |
| 04/01/2004 | US20040063686 Diabetes, major depression, manic depression, anxiety, schizophrenia, sleep disorders |
| 04/01/2004 | US20040063685 Cycloalkene antisepsis drug with antibacterial, antifungal, nonsteroidal antiinflammatory, steroid and/or anticoagulant agents |
| 04/01/2004 | US20040063684 Treatment of oesophageal motility disorders and gastro-oesophageal reflux disease |
| 04/01/2004 | US20040063681 Methods for using gold (III) complexes as anti-tumor and anti-HIV agents |
| 04/01/2004 | US20040063680 Method of treating stroke |
| 04/01/2004 | US20040063679 Amidino and guanidino peptidyl compounds; autoimmune diseases |